Jul
30
Adhansia XR™ (methylphenidate HCl) Extended Release Capsules CII, New ADHD Treatment from Adlon Therapeutics L.P., Now Available Throughout the U.S.
Stamford, Conn., July 30, 2019 – Adlon Therapeutics L.P., a subsidiary of Purdue Pharma L.P., today announced that Adhansia XR™ (methylphenidate hydrochloride) extended-release capsules CII, a central...